The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
“The beta-glucan market is projected to grow at a CAGR of 7.57%”
The beta-glucan market was valued at USD 307.8 million in 2016, and is expected to grow at a CAGR of 7.57%, to reach USD 476.5 million by 2022. The market is primarily driven by factors such as growing health consciousness among consumers and the increasing health expenditure. North America is projected to be the fastest-growing region as the consumers in are gradually becoming aware of the health benefits of oat beta-glucan and its significance in enhancing the body’s immunity. One of the major restraints in the growth of the beta-glucan market is the inconsistency in regulatory norms governing beta-glucan.
“Cereal as a source of beta-glucan led the market with the largest share in 2016”
On the basis of source, the beta-glucan market was led by the cereal segment, followed by yeast. Cereal is sourced mainly from oats and barley as they contain the highest amount of beta-glucan.
“Soluble beta-glucan led the market, in terms of value, with the largest share in 2016”
On the basis of category, the beta-glucan market was led by the soluble segment, followed by insoluble beta-glucan. Products containing soluble beta-glucan are fortified with food to act against diseases such as coronary heart disease, diabetes, and obesity, which are predominant in developed countries. Insoluble beta-glucan is fibrous, which is vital for a healthy digestive system.
“Pharmaceuticals segment is projected to be the fastest-growing application”
The pharmaceuticals application of beta-glucan dominates the market due to its ability to cure problems such as obesity, blood pressure, and diabetes. With the increase in the quality and the arrival of clinically proven products in the market, the trust of consumers is growing for these products. The growing market for functional food & beverages is presenting opportunities for the application of beta-glucan in the food & beverage industry.
“North America: High growth is expected in the beta-glucan market”
North America is projected to be the fastest-growing market for the period considered for this study as the beta-glucan market here is led by its broad applications in various products, along with their health benefits. The North American region is majorly driven by the U.S. market and the increasing incidences of diseases and widespread application of fibers & specialty ingredients in various food products, beverages, and dietary supplements.
Break-up of Primaries:
- By Company Type: Tier 1 – 45 %, Tier 2 – 30%, and Tier 3 – 25%
- By Designation: Director Level: – 15%, C Level – 50%, and Others – 35%
- By Region: North America – 55%, Europe – 20%, Asia-Pacific –20%, and RoW - 5%
Leading players profiled in this report:
- Cargill (U.S.)
- Kerry Group plc (Israel)
- Tate & Lyle (U.K.)
- Royal DSM (Netherlands)
- Ohly (Germany)
- Frutarom (Israel)
- MilliporeSigma (U.S.)
- Super Beta Glucan (U.S.)
- Garuda International (U.S.)
- Lesaffre Human Care (France)
The report segments the beta-glucan market on the basis of category, source, application, and region. In terms of insights, this research report has focused on various levels of analyses?competitive landscape, end-use analysis, and company profiles, which together comprise and discuss the basic views on the emerging & high-growth segments of the global beta-glucan market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons To Buy this report
- To get a comprehensive overview of the beta-glucan market
- To gain information about the top players in this industry, their product portfolios, and key strategies
- To gain insights about the major countries/regions in which the beta-glucan market is flourishing